Retraction of: Scientific Reports https://doi.org/10.1038/srep04136, published online 26 March 2014
The Editors have retracted this article.
An investigation by the US Office of Research Integrity (ORI) [1] has concluded that the protein band arresten (α1(IV)NC1) in Figure 3C (lanes 3–6) was reused in the grant applications R01 CA143128-04 and R01 EY024967-01 to represent a different set of experiments. The ORI was unable to determine which, if any, of these data are correct. The authors have not been able to provide any of the requested original data for this study. The Editors no longer have confidence in the integrity of the data presented in this article.
Yakkanti Akul Sudhakar & Smita C. Pawar disagree with the retraction. The Editors were not able to obtain a current email address for Raj Kumar Verma.
References
Case Summary: Yakkanti, Sudhakar. Federal Register Notice. 84: 61917, https://ori.hhs.gov/sites/default/files/2019-11/2019-24689.pdf (2019).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sudhakar, Y.A., Verma, R.K. & Pawar, S.C. Retraction Note: Type IV collagen α1-chain noncollagenous domain blocks MMP-2 activation both in-vitro and in-vivo. Sci Rep 10, 20995 (2020). https://doi.org/10.1038/s41598-020-76500-9
Published:
DOI: https://doi.org/10.1038/s41598-020-76500-9
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
